CSL’s most recent Final dividend payment of A$1.34 per share was made to shareholders on Thursday, April 1, 2021.
What is the dividend yield of CSL?
CSL is paying dividends since or before Apr 2010. The average dividend yield in last 5 years is 1.17%. The CSL dividend payout ratio is 33.48%.
…
CSL (ASX:CSL) Latest Dividend.
Ex. Dividend Date | Thursday, 04 Mar 2021 |
---|---|
Dividend Amount | 134.14c |
Franking Rate | 0% |
Dividend Type |
What dividend does 2 pay?
TWO Dividend History
Ex/EFF DATE | TYPE | CASH AMOUNT |
---|---|---|
04/15/2020 | CASH | $0.05 |
12/30/2019 | CASH | $0.40 |
09/27/2019 | CASH | $0.40 |
06/28/2019 | CASH | $0.40 |
Is CSL a good buy?
The technical factors of CSL indicate a strong buy. CSL has amazing investor sentiment and the ability to deliver results has earned it a high earnings multiple. … Over the course of 10 years, CSL has delivered market-beating returns of 91.09% per year. Almost doubling investor’s money every year!
Does two have a dividend?
Two Harbors Investment (NYSE:TWO) Dividend Information
Two Harbors Investment pays an annual dividend of $0.68 per share, with a dividend yield of 10.48%.
Does Two Harbors pay a dividend?
The previous Two Harbors Investment Corp dividend was 17c and it went ex 2 months ago and it was paid 19 days ago. There are typically 4 dividends per year (excluding specials).
…
Dividend Summary.
Summary | Previous dividend | Next dividend |
---|---|---|
Pay date | 29 Jul 2021 (Thu) | 25 Oct 2021 (Mon) |
Is Two Harbors a good investment?
Two Harbors Investment has received a consensus rating of Hold. The company’s average rating score is 2.22, and is based on 2 buy ratings, 7 hold ratings, and no sell ratings.
Why is CSL price rising?
Australian biotech CSL Ltd on Thursday reported a 45% rise in half-year profit, boosted by higher demand for its vaccines and blood plasma products. Australian biotech CSL Ltd on Thursday reported a 45% rise in half-year profit, boosted by higher demand for its vaccines and blood plasma products.
Is CSL share a buy?
UBS is the most bullish broker with a buy rating and CSL share price target of $330.00. This implies potential upside of 18.2% over the next 12 months. UBS’ analysts are forecasting a CSL dividend of ~$2.33 per share in 2021.